However, Seeble et al. (41) reported a correlation between ANA titers and long COVID-19, including neurocognitive symptoms and dyspnea, and speculated a potential contribution of autoimmunity for the persistence of symptons. This evidence concerns the gene BTG3 and COVID-19.